Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 pathobiology in Parkinson's disease
Ian Martin, Jungwoo Wren Kim, Valina L. Dawson, et al.
Journal of Neurochemistry (2014) Vol. 131, Iss. 5, pp. 554-565
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger, Francesca Tonelli, Genta Ito, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 941
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier, José Á. Obeso, Glenda M. Halliday
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 2, pp. 101-113
Open Access | Times Cited: 902
Parkinson’s Disease in Women and Men: What’s the Difference?
Silvia Cerri, Liudmila Mus, Fabio Blandini
Journal of Parkinson s Disease (2019) Vol. 9, Iss. 3, pp. 501-515
Open Access | Times Cited: 590
The genetics of Parkinson disease
Hao Deng, Peng Wang, Joseph Jankovic
Ageing Research Reviews (2017) Vol. 42, pp. 72-85
Closed Access | Times Cited: 471
Extracellular vesicles in neurodegenerative disease — pathogenesis to biomarkers
Alexander G. Thompson, Elizabeth Gray, Sabrina M. Heman-Ackah, et al.
Nature Reviews Neurology (2016) Vol. 12, Iss. 6, pp. 346-357
Open Access | Times Cited: 351
Mitochondrial Dysfunction in Parkinson’s Disease
Hyo Eun Moon, Sun Ha Paek
Experimental Neurobiology (2015) Vol. 24, Iss. 2, pp. 103-116
Open Access | Times Cited: 350
α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models
Joseph R. Mazzulli, Friederike Zunke, Ole Isacson, et al.
Proceedings of the National Academy of Sciences (2016) Vol. 113, Iss. 7, pp. 1931-1936
Open Access | Times Cited: 326
Oxidative stress and regulated cell death in Parkinson’s disease
Pedro A. Dionísio, Joana D. Amaral, Cecília M. P. Rodrigues
Ageing Research Reviews (2021) Vol. 67, pp. 101263-101263
Closed Access | Times Cited: 295
LRRK2 and its substrate Rab GTPases are sequentially targeted onto stressed lysosomes and maintain their homeostasis
Tomoya Eguchi, Tomoki Kuwahara, Maria Sakurai, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 39
Open Access | Times Cited: 278
Inhibitor treatment of peripheral mononuclear cells from Parkinson’s disease patients further validates LRRK2 dephosphorylation as a pharmacodynamic biomarker
G. Perera, Madelaine Ranola, Dominic B. Rowe, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 258
Emerging therapies in Parkinson disease — repurposed drugs and new approaches
Ahmad Elkouzi, Vinata Vedam‐Mai, Robert S. Eisinger, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 4, pp. 204-223
Open Access | Times Cited: 256
Animal models of α-synucleinopathy for Parkinson disease drug development
James B. Koprich, Lorraine V. Kalia, Jonathan M. Brotchie
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 9, pp. 515-529
Closed Access | Times Cited: 193
LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10
Fieke Wauters, Tom Cornelissen, Dorien Imberechts, et al.
Autophagy (2019) Vol. 16, Iss. 2, pp. 203-222
Open Access | Times Cited: 165
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease
Andrew B. West
Experimental Neurology (2017) Vol. 298, pp. 236-245
Open Access | Times Cited: 154
The Role of LRRK2 in Neurodegeneration of Parkinson Disease
Rui Qin, Haibo Ni, Di Li, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 9, pp. 1348-1357
Open Access | Times Cited: 145
Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
Palak Amin, Marcus A. Florez, Ayaz Najafov, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 26
Open Access | Times Cited: 129
Neuropathology of α‐synuclein propagation and braak hypothesis
Heather McCann, Heidi Cartwright, Glenda M. Halliday
Movement Disorders (2015) Vol. 31, Iss. 2, pp. 152-160
Closed Access | Times Cited: 116
LRRK2 maintains mitochondrial homeostasis and regulates innate immune responses to Mycobacterium tuberculosis
Chi G. Weindel, Samantha L. Bell, Krystal J. Vail, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 102
Synapses in neurodegenerative diseases
Jae Ryul Bae, Sung Hyun Kim
BMB Reports (2017) Vol. 50, Iss. 5, pp. 237-246
Open Access | Times Cited: 96
Modeling Parkinson’s Disease in Drosophila: What Have We Learned for Dominant Traits?
Yulan Xiong, Jianzhong Yu
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 87
Robust kinase- and age-dependent dopaminergic and norepinephrine neurodegeneration in LRRK2 G2019S transgenic mice
Yulan Xiong, Stewart Neifert, Senthilkumar S. Karuppagounder, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 7, pp. 1635-1640
Open Access | Times Cited: 86
Current perspective of mitochondrial biology in Parkinson's disease
Navneet Ammal Kaidery, Bobby Thomas
Neurochemistry International (2018) Vol. 117, pp. 91-113
Open Access | Times Cited: 84
Antisense Drugs Make Sense for Neurological Diseases
C. Frank Bennett, Holly Kordasiewicz, Don W. Cleveland
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 831-852
Open Access | Times Cited: 84
Rescue of α-synuclein aggregation in Parkinson’s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking
Iva Stojkovska, Willayat Yousuf Wani, Friederike Zunke, et al.
Neuron (2021) Vol. 110, Iss. 3, pp. 436-451.e11
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top